Nanotechnology in Medicine V: Converging Disciplines to Advance Next-Generation Therapeutics
The upcoming conference, "Nanotechnology in Medicine V: Converging Disciplines to Advance Next-Generation Therapeutics," will bring together leading experts and innovators to explore the transformative potential of nanotechnology in medical applications. This year's sessions will cover a diverse range of topics, each critical to advancing the field and improving patient outcomes.
- Low Cost Synthesis and Manufacturing, and Sustainable Methods: This session will delve into innovative approaches for the cost-effective and sustainable production of nanomaterials, ensuring accessibility and environmental responsibility in nanomedicine.
- Advanced In Vitro Tools and Models: Attendees will explore cutting-edge in vitro tools and models that enhance our understanding of nanomedicine interactions and efficacy, paving the way for more accurate and predictive preclinical studies.
- Leveraging AI to Enhance Nanomedicine (Including Drug Repurposing): This session will highlight the integration of artificial intelligence in nanomedicine, focusing on how AI can optimize drug repurposing and enhance the precision of therapeutic interventions.
- Translational Drug Delivery: Experts will discuss the latest advancements in translational drug delivery systems, emphasizing the journey from bench to bedside and the challenges and successes in clinical applications.
- Living Therapeutics (Biocontainment of Next-Gen Therapeutics): This session will cover the development and biocontainment of living therapeutics, exploring innovative strategies to harness and control biological systems for therapeutic purposes.
- Supporting Trainee to Professional Pipeline: Recognizing the importance of nurturing the next generation of scientists, this session will focus on strategies and programs that support the transition from trainee to professional in the field of nanomedicine.
- Tissue Engineering: Attendees will learn about the latest breakthroughs in tissue engineering, including the use of nanotechnology to create more effective and functional tissue constructs for regenerative medicine.
- Immunoengineering: This session will explore the intersection of nanotechnology and immunology, highlighting how engineered nanomaterials can modulate immune responses for improved therapeutic outcomes.
Conference Organization
Co-Chairs
Rohan Fernandes, PhD
Associate Professor of Bioengineering
University of Maryland College Park, USA
Juliane Nguyen, PhD
Professor, Division of Pharmacoengineering and Molecular Pharmaceutics, Department of Biomedical Engineering
University of North Carolina, USA
ECI Technical Liaison
Joye Bramble, PhD
Vice President
Biopharmaceutical Development at Eisai US
Sponsor Information
Previous Conferences in This Series
Nanotechnology in Medicine: From Molecules to Humans
July 3-7, 2016
Hernstein, Austria
Conference Chairs
Lola Eniola-Adefeso (Department of Chemical Engineering, University of Michigan, USA)
Paolo Decuzzi (Italian Institute of Technology, Italy)
Nanotechnology in Medicine II: Bridging Translational in vitro and in vivo Interfaces
June 5-9, 2018
Grande Real Santa Eulalia Hotel
Albufeira, Portugal
Conference Chairs
Millicent Sullivan
Department of Chemical & Biomolecular Engineering, University of Delaware, USA
Josué Sznitman
Department of Biomedical Engineering, Technion-Israel Institute of Technology, Israel
Nanotechnology in Medicine III: Enabling Next Generation Therapies
May 15-20, 2022
Grand Hotel San Michele
Cetraro (Calabria), Italy
Conference Chairs
Milica Radisic
University of Toronto, Canada
Victor Shahin
University of Münster, Germany
Nanotechnology in Medicine IV: Physical Triggers and Advanced Materials
May 12 – 16, 2024
Hotel dos Templários
Tomar, Portugal
Conference Chairs
Shyni Varghese
Duke University, USA
Stefaan DeSmedt
Ghent University, Belgium
Kaushal Rege
Arizona State University, USA